Exonization of Alu-generated Splice Variants in the Survivin Gene of Human and Non-human Primates

Journal of Molecular Biology

Volumn 366, Issue 4, 2007, Pages 1055-1063

  Mola, Gemma ^a   Vela, Elena ^b   Fernández Figueras, Ma Teresa ^a   Isamat, Marcos ^b   Muñoz Mármol, Ana M ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b Laboratorios Dr Echevarne   (Spain)

Author keywords

alternative splicing; Alu exonization; nonsense mediated decay; premature termination codon; survivin

Indexed keywords

NUCLEOTIDE DERIVATIVE; SURVIVIN;

ALU SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EXON; GENE INSERTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RNA SPLICING; SEQUENCE ANALYSIS; STOP CODON;

PRIMATES;

EID: 33846694462     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.11.089     Document Type: Article

References (50)

1. Adida C., Crotty P.L., McGrath J., Berrebi D., Diebold J., and Altieri D.C. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am. J. Pathol. 152 (1998) 43-49
2. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 3 (1997) 917-921
3. Li F., Ackermann E.J., Bennett C.F., Rothermel A.L., Plescia J., Tognin S., et al. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nature Cell Biol. 1 (1999) 461-466
4. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
5. Mahotka C., Wenzel M., Springer E., Gabbert H.E., and Gerharz C.D. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 59 (1999) 6097-6102
6. Badran A., Yoshida A., Ishikawa K., Goi T., Yamaguchi A., Ueda T., and Inuzuka M. Identification of a novel splice variant of the human anti-apoptopsis gene survivin. Biochem. Biophys. Res. Commun. 314 (2004) 902-907
7. Caldas H., Honsey L.E., and Altura R.A. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Mol. Cancer 4 (2005) 11
8. Caldas H., Jiang Y., Holloway M.P., Fangusaro J., Mahotka C., Conway E.M., and Altura R.A. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24 (2005) 1994-2007
9. Mahotka C., Liebmann J., Wenzel M., Suschek C.V., Schmitt M., Gabbert H.E., and Gerharz C.D. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 9 (2002) 1334-1342
10. Mahotka C., Krieg T., Krieg A., Wenzel M., Suschek C.V., Heydthausen M., et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int. J. Cancer 100 (2002) 30-36
11. Vegran F., Boidot R., Oudin C., Riedinger J.M., and Lizard-Nacol S. Distinct expression of Survivin splice variants in breast carcinomas. Int. J. Oncol. 27 (2005) 1151-1157
12. Stamm S., Ben-Ari S., Rafalska I., Tang Y., Zhang Z., Toiber D., et al. Function of alternative splicing. Gene 344 (2005) 1-20
13. Lewis B.P., Green R.E., and Brenner S.E. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl Acad. Sci. USA 100 (2003) 189-192
14. Maquat L.E. Nonsense-mediated mRNA decay in mammals. J. Cell Sci. 118 (2005) 1773-1776
15. Alonso C.R. Nonsense-mediated RNA decay: a molecular system micromanaging individual gene activities and suppressing genomic noise. Bioessays 27 (2005) 463-466
16. Lian Y., and Garner H.R. Evidence for the regulation of alternative splicing via complementary DNA sequence repeats. Bioinformatics 21 (2005) 1358-1364
17. Hui J., and Bindereif A. Alternative pre-mRNA splicing in the human system: unexpected role of repetitive sequences as regulatory elements. Biol. Chem. 386 (2005) 1265-1271
18. Sorek R., Ast G., and Graur D. Alu-containing exons are alternatively spliced. Genome Res. 12 (2002) 1060-1067
19. Lei H., and Vorechovsky I. Identification of splicing silencers and enhancers in sense Alus: a role for pseudo-acceptors in splice site repression. Mol. Cell Biol. 25 (2005) 6912-6920
20. Mighell A.J., Markham A.F., and Robinson P.A. Alu sequences. FEBS Letters 417 (1997) 1-5
21. Batzer M.A., Deininger P.L., Hellmann-Blumberg U., Jurka J., Labuda D., Rubin C.M., et al. Standardized nomenclature for Alu repeats. J. Mol. Evol. 42 (1996) 3-6
22. Grover D., Kannan K., Brahmachari S.K., and Mukerji M. ALU-ring elements in the primate genomes. Genetica 124 (2005) 273-289
23. Maquat L.E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nature Rev. Mol. Cell Biol. 5 (2004) 89-99
24. Jurka J., and Milosavljevic A. Reconstruction and analysis of human Alu genes. J. Mol. Evol. 32 (1991) 105-121
25. Makalowski W. Genomic scrap yard: how genomes utilize all that junk. Gene 259 (2000) 61-67
26. Meng H., Lu C., Mabuchi H., and Tanigawa N. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Letters 216 (2004) 147-155
27. Taubert H., Kappler M., Bache M., Bartel F., Kohler T., Lautenschlager C., et al. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients. Oncogene 24 (2005) 5258-5261
28. Takashima H., Nakajima T., Moriguchi M., Sekoguchi S., Nishikawa T., Watanabe T., et al. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma. Liver Int. 25 (2005) 77-84
29. Fangusaro J.R., Jiang Y., Holloway M.P., Caldas H., Singh V., Boue D.R., et al. Survivin, Survivin-2B, and Survivin-deltaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome. Br. J. Cancer 92 (2005) 359-365
30. Liu W.M., Chu W.M., Choudary P.V., and Schmid C.W. Cell stress and translational inhibitors transiently increase the abundance of mammalian SINE transcripts. Nucl. Acids Res. 23 (1995) 1758-1765
31. Chesnokov I., Chu W.M., Botchan M.R., and Schmid C.W. p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner. Mol. Cell Biol. 16 (1996) 7084-7088
32. Tang R.B., Wang H.Y., Lu H.Y., Xiong J., Li H.H., Qiu X.H., and Liu H.Q. Increased level of polymerase III transcribed Alu RNA in hepatocellular carcinoma tissue. Mol. Carcinog. 42 (2005) 93-96
33. Ichiki Y., Hanagiri T., Takenoyama M., Baba T., Fukuyama T., Nagata Y., et al. Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapy. Lung Cancer 48 (2005) 281-289
34. Mendell J.T., Sharifi N.A., Meyers J.L., Martinez-Murillo F., and Dietz H.C. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nature Genet. 36 (2004) 1073-1078
35. Neu-Yilik G., Gehring N.H., Hentze M.W., and Kulozik A.E. Nonsense-mediated mRNA decay: from vacuum cleaner to Swiss army knife. Genome Biol. 5 (2004) 218
36. Hillman R.T., Green R.E., and Brenner S.E. An unappreciated role for RNA surveillance. Genome Biol. 5 (2004) R8
37. Donnadieu E., Jouvin M.H., Rana S., Moffatt M.F., Mockford E.H., Cookson W.O., and Kinet J.P. Competing functions encoded in the allergy-associated F(c)epsilonRIbeta gene. Immunity 18 (2003) 665-674
38. Dreumont N., Maresca A., Boisclair-Lachance J.F., Bergeron A., and Tanguay R.M. A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay. BMC Mol. Biol. 6 (2005) 1
39. Skandalis A., and Uribe E. A survey of splice variants of the human hypoxanthine phosphoribosyl transferase and DNA polymerase beta genes: products of alternative or aberrant splicing?. Nucl. Acids Res. 32 (2004) 6557-6564
40. Krull M., Brosius J., and Schmitz J. Alu-SINE exonization: en route to protein-coding function. Mol. Biol. Evol. 22 (2005) 1702-1711
41. Grover D., Mukerji M., Bhatnagar P., Kannan K., and Brahmachari S.K. Alu repeat analysis in the complete human genome: trends and variations with respect to genomic composition. Bioinformatics 20 (2004) 813-817
42. El-Sawy M., and Deininger P. Tandem insertions of Alu elements. Cytogenet. Genome Res. 108 (2005) 58-62
43. Jurka J., Kohany O., Pavlicek A., Kapitonov V.V., and Jurka M.V. Duplication, coclustering, and selection of human Alu retrotransposons. Proc. Natl Acad. Sci. USA 101 (2004) 1268-1272
44. Grover D., Majumder P.P.C.,B.R., Brahmachari S.K., and Mukerji M. Non-random distribution of alu elements in genes of various functional categories: insight from analysis of human chromosomes 21 and 22. Mol. Biol. Evol. 20 (2003) 1420-1424
45. Gibbons R., and Dugaiczyk A. Phylogenetic roots of Alu-mediated rearrangements leading to cancer. Genome 48 (2005) 160-167
46. Ishii N., Maier D., Merlo A., Tada M., Sawamura Y., Diserens A.C., and Van Meir E.G. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9 (1999) 469-479
47. Villa A., Snyder E.Y., Vescovi A., and Martinez-Serrano A. Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp. Neurol. 161 (2000) 67-84
48. Roca X., Mate J.L., Ariza A., Munoz-Marmol A.M., von Uexkull-Guldeb C., Pellicer I., et al. CD44 isoform expression follows two alternative splicing pathways in breast tissue. Am. J. Pathol. 153 (1998) 183-190
49. Senapathy P., Shapiro M.B., and Harris N.L. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol. 183 (1990) 252-278
50. Goodman M., Porter C.A., Czelusniak J., Page S.L., Schneider H., Shoshani J., et al. Toward a phylogenetic classification of Primates based on DNA evidence complemented by fossil evidence. Mol. Phylogenet. Evol. 9 (1998) 585-598